{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:09:44Z","timestamp":1793196584517,"version":"4.5.0"},"reference-count":198,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":84,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.rgmxen.2023.12.002","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T16:39:10Z","timestamp":1712248750000},"page":"121-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda"],"prefix":"10.1016","volume":"89","author":[{"given":"M.A.","family":"Valdovinos D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Amieva-Balmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Carmona-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Coss-Adame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"G\u00f3mez-Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gonz\u00e1lez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Huerta-Iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Morel-Cerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Remes-Troche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Tamayo-de la Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Torres-Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.R.","family":"Valdovinos-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"V\u00e1zquez-Elizondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Villar-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Arenas-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmxen.2023.12.002_bib0005","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41572-021-00287-w","article-title":"Gastro-oesophageal reflux disease","volume":"7","author":"Fass","year":"2021","journal-title":"Nat Rev Dis Prim."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5056\/jnm17097","article-title":"Reflux hypersensitivity: a new functional esophageal disorder","volume":"23","author":"Yamasaki","year":"2017","journal-title":"J Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/gut.2004.051821","article-title":"Epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"54","author":"Dent","year":"2005","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2017.07.045","article-title":"Presentation and epidemiology of gastroesophageal reflux disease","volume":"154","author":"Richter","year":"2018","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0035","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/MEG.0b013e328365c359","article-title":"Changes in symptoms and lifestyle factors in patients seeking healthcare for gastrointestinal symptoms: an 18-year follow-up study","volume":"25","author":"Stake-Nilsson","year":"2013","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/17512433.2020.1752664","article-title":"Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease","volume":"13","author":"Savarino","year":"2020","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.gastro.2017.09.047","article-title":"Pathophysiology of gastroesophageal reflux disease","volume":"154","author":"Tack","year":"2018","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0050","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1053\/gast.2000.20191","article-title":"Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations","volume":"119","author":"Van-Herwaarden","year":"2000","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0055","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bpg.2007.12.007","article-title":"Approaches to the diagnosis and grading of hiatal hernia","volume":"22","author":"Kahrilas","year":"2008","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/gut.2005.074690","article-title":"Determinants of perception of heartburn and regurgitation","volume":"55","author":"Bredenoord","year":"2006","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13104","article-title":"Classification of esophageal motor findings in gastro\u2010esophageal reflux disease: conclusions from an international consensus group","volume":"29","author":"Gyawali","year":"2017","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/gutjnl-2023-330616","article-title":"Updates to the modern diagnosis of GERD: Lyon consensus 2.0","volume":"73","author":"Gyawali","year":"2024","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0075","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.cgh.2014.11.034","article-title":"Effects of anxiety and depression in patients with gastroesophageal reflux disease","volume":"13","author":"Kessing","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/gut.2009.200063","article-title":"Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study","volume":"59","author":"Dent","year":"2010","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0085","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.cgh.2023.01.040","article-title":"AGA clinical practice update on the diagnosis and management of extraesophageal gastroesophageal reflux disease: expert review","volume":"21","author":"Chen","year":"2023","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0090","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2036.2010.04245.x","article-title":"The influence of environmental risk factors in hospitalization for gastro\u2010oesophageal reflux disease\u2010related diagnoses in the United States","volume":"31","author":"Thukkani","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0095","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cgh.2022.01.025","article-title":"AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review","volume":"20","author":"Yadlapati","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0105","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1572-0241.2005.41657.x","article-title":"Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis","volume":"100","author":"Cremonini","year":"2005","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0110","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/archinte.159.18.2161","article-title":"Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease","volume":"159","author":"Fass","year":"1999","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MCG.0000000000001686","article-title":"Diagnostic accuracy of the proton pump inhibitor test in gastroesophageal reflux disease and noncardiac chest pain: a systematic review and meta-analysis","volume":"57","author":"Ghoneim","year":"2022","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0120","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/j.1572-0241.2006.00844.x","article-title":"Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials","volume":"101","author":"Qadeer","year":"2006","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MCG.0000000000000324","article-title":"Proton pump inhibitor therapy for the treatment of laryngopharyngeal reflux: a meta-analysis of randomized controlled trials","volume":"50","author":"Guo","year":"2016","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0130","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/lary.27591","article-title":"Clinical outcomes of laryngopharyngeal reflux treatment: a systematic review and meta\u2010analysis","volume":"129","author":"Lechien","year":"2019","journal-title":"Laryngoscope."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification","volume":"45","author":"Lundell","year":"1999","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0140","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","article-title":"Modern diagnosis of GERD: the Lyon Consensus","volume":"67","author":"Gyawali","year":"2018","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0145","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1365-2036.2010.04468.x","article-title":"The impact of pre\u2010endoscopy proton pump inhibitor use on the classification of non\u2010erosive reflux disease and erosive oesophagitis","volume":"32","author":"Gaddam","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0150","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2016.5657","article-title":"Association of acute gastroesophageal reflux disease with esophageal histologic changes","volume":"315","author":"Dunbar","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0155","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1053\/j.gastro.2018.03.003","article-title":"New eosinophilic esophagitis concepts call for change in proton pump inhibitor management before diagnostic endoscopy","volume":"154","author":"Odiase","year":"2018","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0160","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/00365521.2011.579154","article-title":"Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease","volume":"46","author":"Cheong","year":"2011","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12876-017-0693-7","article-title":"Gastroesophageal flap valve reflected EGJ morphology and correlated to acid reflux","volume":"17","author":"Xie","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0170","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.cgh.2022.06.003","article-title":"AGA Clinical practice update on new technology and innovation for surveillance and screening in Barrett\u2019s esophagus: expert review","volume":"20","author":"Muthusamy","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.mcg.0000190753.25750.0e","article-title":"Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system","volume":"40","author":"Ahlawat","year":"2006","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0180","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/j.cgh.2020.01.031","article-title":"Prolonged wireless pH monitoring in patients with persistent reflux symptoms despite proton pump inhibitor therapy","volume":"18","author":"Hasak","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/j.gastro.2020.09.013","article-title":"Ambulatory reflux monitoring guides proton pump inhibitor discontinuation in patients with gastroesophageal reflux symptoms: a clinical trial","volume":"160","author":"Yadlapati","year":"2021","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0190","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1053\/j.gastro.2021.07.004","article-title":"Value of pH impedance monitoring while on twice-daily proton pump inhibitor therapy to identify need for escalation of reflux management","volume":"161","author":"Gyawali","year":"2021","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0195","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14075","article-title":"ESNM\/ANMS consensus paper: diagnosis and management of refractory gastro\u2010esophageal reflux disease","volume":"33","author":"Zerbib","year":"2021","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/nmo.12457","article-title":"The diagnosis of gastro\u2010esophageal reflux disease cannot be made with barium esophagograms","volume":"27","author":"Saleh","year":"2015","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0205","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.14309\/ajg.0000000000000731","article-title":"ACG clinical guidelines: diagnosis and management of achalasia","volume":"115","author":"Vaezi","year":"2020","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ajg.2016.1","article-title":"High-resolution manometry improves the diagnosis of esophageal motility disorders in patients with dysphagia: a randomized multicenter study","volume":"111","author":"Roman","year":"2016","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11894-019-0704-7","article-title":"The utility of esophageal motility testing in gastroesophageal reflux disease (GERD)","volume":"21","author":"Garbarino","year":"2019","journal-title":"Curr Gastroenterol Rep."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0220","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/ajg.2014.165","article-title":"The pathophysiology, diagnosis and treatment of excessive belching symptoms","volume":"109","author":"Kessing","year":"2014","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0225","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/nmo.12477","article-title":"The Chicago Classification of esophageal motility disorders, v3.0","volume":"27","author":"Kahrilas","year":"2015","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0230","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s40265-013-0101-8","article-title":"Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment","volume":"73","author":"Hom","year":"2013","journal-title":"Drugs."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0235","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1046\/j.1365-2036.2003.01606.x","article-title":"Prevalence of extra\u2010oesophageal manifestations in gastro\u2010oesophageal reflux disease: an analysis based on the ProGERD Study","volume":"17","author":"Jaspersen","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0240","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.chest.2016.08.1458","article-title":"Chronic cough due to gastroesophageal reflux in adults CHEST guideline and expert panel report","volume":"150","author":"Kahrilas","year":"2016","journal-title":"Chest."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0245","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.3748\/wjg.v18.i32.4363","article-title":"How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?","volume":"18","author":"de-Bortoli","year":"2012","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0250","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s11605-016-3212-1","article-title":"Importance of esophageal manometry and pH monitoring for the evaluation of otorhinolaryngologic (ENT) manifestations of GERD. A multicenter study","volume":"20","author":"Herbella","year":"2016","journal-title":"J Gastrointest Surg."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0255","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doy072","article-title":"Relationship between extralaryngeal endoscopic findings, proton pump inhibitor (PPI) response, and pH measures in suspected laryngopharyngeal reflux","volume":"32","author":"Agrawal","year":"2019","journal-title":"Dis Esophagus."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0260","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.3390\/jcm9082559","article-title":"Extra-esophageal presentation of gastroesophageal reflux disease: 2020 update","volume":"9","author":"Durazzo","year":"2020","journal-title":"J Clin Med."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-022-00370-w","article-title":"Cough hypersensitivity and chronic cough","volume":"8","author":"Chung","year":"2022","journal-title":"Nat Rev Dis Prim."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0270","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/apt.12919","article-title":"Reflux pattern and role of impedance\u2010pH variables in predicting PPI response in patients with suspected GERD\u2010related chronic cough","volume":"40","author":"Ribolsi","year":"2014","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0275","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13707","article-title":"Gastroesophageal reflux disease and chronic cough: A possible mechanism elucidated by ambulatory pH\u2010impedance\u2010pressure monitoring","volume":"31","author":"Li","year":"2019","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0280","doi-asserted-by":"crossref","DOI":"10.1177\/14799731211006682","article-title":"Diagnostic accuracy of multichannel intraluminal impedance-pH monitoring for gastroesophageal reflux-induced chronic cough","volume":"18","author":"Li","year":"2021","journal-title":"Chronic Respir Dis."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0285","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221117455","article-title":"Diagnostic value of reflux episodes in gastroesophageal reflux-induced chronic cough: a novel predictive indicator","volume":"13","author":"Wang","year":"2022","journal-title":"Ther Adv Chronic Dis."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0290","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1751-2980.2011.00519.x","article-title":"Is impedance pH monitoring superior to the conventional 24\u2010h pH meter in the evaluation of patients with laryngorespiratory symptoms suspected to be due to gastroesophageal reflux disease?","volume":"12","author":"Ang","year":"2011","journal-title":"J Dig Dis."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0295","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/ajg.2012.342","article-title":"Symptom reports are not reliable during ambulatory reflux monitoring","volume":"107","author":"Kavitt","year":"2012","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0300","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.gastro.2010.06.050","article-title":"Acoustic cough\u2014reflux associations in chronic cough: potential triggers and mechanisms","volume":"139","author":"Smith","year":"2010","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0305","doi-asserted-by":"crossref","first-page":"e1319","DOI":"10.1111\/nmo.13129","article-title":"Reflux\u2010cough syndrome: assessment of temporal association between reflux episodes and cough bursts","volume":"29","author":"Herregods","year":"2017","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0310","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/ajg.2016.145","article-title":"Oropharyngeal pH testing does not predict response to proton pump inhibitor therapy in patients with laryngeal symptoms","volume":"111","author":"Yadlapati","year":"2016","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0315","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00408-021-00496-w","article-title":"Heartburn as a marker of the success of acid suppression therapy in chronic cough","volume":"199","author":"Badri","year":"2021","journal-title":"Lung."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0320","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.14309\/ajg.0000000000000734","article-title":"ACG clinical guidelines: clinical use of esophageal physiologic testing","volume":"115","author":"Gyawali","year":"2020","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0325","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3746\/pnf.2021.26.4.367","article-title":"Dietary intake in relation to the risk of reflux disease: a systematic review","volume":"26","author":"Heidarzadeh-Esfahani","year":"2021","journal-title":"Prev Nutr Food Sci."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0330","first-page":"21","article-title":"Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet","volume":"72","author":"Taraszewska","year":"2021","journal-title":"Rocz Pa\u0144stwowego Zak\u0142adu Hig."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0335","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/TCRM.S296680","article-title":"Dietary and lifestyle factors related to gastroesophageal reflux disease: a systematic review","volume":"17","author":"Zhang","year":"2021","journal-title":"Ther Clin Risk Manag."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0340","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10620-020-06414-z","article-title":"Elimination of dietary triggers is successful in treating symptoms of gastroesophageal reflux disease","volume":"66","author":"Tosetti","year":"2021","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0345","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamainternmed.2020.7238","article-title":"Association of diet and lifestyle with the risk of gastroesophageal reflux disease symptoms in us women","volume":"181","author":"Mehta","year":"2021","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0350","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000509208","article-title":"Combined healthy lifestyle is inversely associated with upper gastrointestinal disorders among iranian adults","volume":"39","author":"Saneei","year":"2021","journal-title":"Dig Dis."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0355","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14385","article-title":"Systematic review: Clinical effectiveness of interventions for the treatment of nocturnal gastroesophageal reflux","volume":"34","author":"Schuitenmaker","year":"2022","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0360","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cgh.2015.04.176","article-title":"Lifestyle intervention in gastroesophageal reflux disease","volume":"14","author":"Ness-Jensen","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0365","article-title":"Role of non-pharmacological interventions and weight loss in the management of gastroesophageal reflux disease in obese individuals: a systematic review","volume":"14","author":"Mukhtar","year":"2022","journal-title":"Cureus."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0370","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.3748\/wjg.v11.i26.4067","article-title":"Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis","volume":"11","author":"Wang","year":"2005","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0375","first-page":"208","article-title":"Diagn\u00f3stico y tratamiento de la enfermedad por reflujo gastroesof\u00e1gico: recomendaciones de la Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda","volume":"81","author":"Huerta-Iga","year":"2016","journal-title":"Rev Gastroenterol M\u00e9x."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0380","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.cgh.2006.09.013","article-title":"Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials","volume":"4","author":"Gralnek","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0385","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17425255.2018.1461835","article-title":"Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine","volume":"14","author":"Rouby","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0390","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2036.2007.03381.x","article-title":"Systematic review: maintenance treatment of gastro\u2010oesophageal reflux disease with proton pump inhibitors taken \u2018on-demand\u2019","volume":"26","author":"Pace","year":"2007","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0395","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/gut.33.8.1016","article-title":"Three-year follow up of patients with gastrooesophageal reflux disease","volume":"33","author":"Schindlbeck","year":"1992","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0400","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","article-title":"Complications of proton pump inhibitor therapy","volume":"153","author":"Vaezi","year":"2017","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0405","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1038\/ctg.2015.39","article-title":"Potassium-competitive acid blockers (P-CABs): are they finally ready for prime time in acid-related disease?","volume":"6","author":"Hunt","year":"2015","journal-title":"Clin Transl Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0410","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2016.08.001","article-title":"Potassium-competitive acid blockers: advanced therapeutic option for acid-related diseases","volume":"168","author":"Inatomi","year":"2016","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0415","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.3748\/wjg.v28.i28.3608","article-title":"Potassium-competitive acid blockers and gastroesophageal reflux disease","volume":"28","author":"Leowattana","year":"2022","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0420","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/apt.15185","article-title":"Randomised phase 3 trial: tegoprazan, a novel potassium\u2010competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis","volume":"49","author":"Lee","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0425","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.gastro.2022.09.041","article-title":"Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: a randomized trial","volume":"164","author":"Laine","year":"2023","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0430","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/apt.16477","article-title":"Randomised clinical trial: comparison of tegoprazan and placebo in non\u2010erosive reflux disease","volume":"54","author":"Kim","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0435","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/1751-2980.13028","article-title":"Chinese expert consensus on gastroesophageal reflux disease in 2020","volume":"22","author":"Xiao","year":"2021","journal-title":"J Dig Dis."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0440","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5056\/jnm21077","article-title":"2020 Seoul Consensus on the diagnosis and management of gastroesophageal reflux disease","volume":"27","author":"Jung","year":"2021","journal-title":"J Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0445","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/apt.17255","article-title":"Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis","volume":"57","author":"Cho","year":"2023","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0450","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/apt.13914","article-title":"Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non\u2010erosive reflux disease \u2013 efficacy of Esoxx, a hyaluronic acid\u2013chondroitin sulphate based bioadhesive formulation","volume":"45","author":"Savarino","year":"2017","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0455","article-title":"Short\u2010term treatment with proton pump inhibitors, H2\u2010receptor antagonists and prokinetics for gastro\u2010oesophageal reflux disease\u2010like symptoms and endoscopy negative reflux disease","volume":"5","author":"Sigterman","year":"2006","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0460","article-title":"Medical treatments in the short term management of reflux oesophagitis","volume":"12","author":"Khan","year":"2007","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0465","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2036.1995.tb00347.x","article-title":"A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group","volume":"9","author":"Robinson","year":"1995","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00228-008-0576-5","article-title":"Relative potency of proton-pump inhibitors\u2014comparison of effects on intragastric pH","volume":"65","author":"Kirchheiner","year":"2009","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0475","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2017.09.033","article-title":"Interchangeable use of proton pump inhibitors based on relative potency","volume":"16","author":"Graham","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0480","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/br.2016.828","article-title":"Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia","volume":"6","author":"Asaoka","year":"2017","journal-title":"Biomed Rep."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0485","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1365-2036.1999.00564.x","article-title":"On demand therapy with omeprazole for the long\u2010term management of patients with heartburn without oesophagitis\u2014a placebo\u2010controlled randomized trial","volume":"13","author":"Lind","year":"1999","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0490","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.14309\/01.ajg.0000858200.17525.4a","article-title":"Efficacy and safety of on-demand vonoprazan versus placebo in the treatment of heartburn in symptomatic nonerosive reflux disease (NERD) patients: a phase 2 randomized controlled trial","volume":"117","author":"Fass","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0495","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs","volume":"292","author":"Laheij","year":"2004","journal-title":"JAMA."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0500","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0505","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0510","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1572-0241.2003.07665.x","article-title":"Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs","volume":"98","author":"Inadomi","year":"2003","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0515","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5056\/jnm18029","article-title":"Potent Potassium-competitive acid blockers: a new era for the treatment of acid-related diseases","volume":"24","author":"Oshima","year":"2018","journal-title":"J Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0520","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1111\/jgh.16017","article-title":"A comparison of efficacy and safety of potassium\u2010competitive acid blocker and proton pump inhibitor in gastric acid\u2010related diseases: a systematic review and meta\u2010analysis","volume":"37","author":"Simadibrata","year":"2022","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0525","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.2169\/internalmedicine.2535-18","article-title":"Vonoprazan versus lansoprazole for the initial treatment of reflux esophagitis: a cost-effectiveness analysis in Japan","volume":"58","author":"Habu","year":"2019","journal-title":"Intern Med."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0530","first-page":"693","article-title":"Potassium-competitive acid blockers: present and potential utility in the armamentarium for acid peptic disorders","volume":"18","author":"Wong","year":"2022","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0535","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/jgh.15758","article-title":"Thailand guideline 2020 for medical management of gastroesophageal reflux disease","volume":"37","author":"Maneerattanaporn","year":"2022","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0540","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00535-022-01861-z","article-title":"Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021","volume":"57","author":"Iwakiri","year":"2022","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0545","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6417526","article-title":"On-demand therapy with proton pump inhibitors for maintenance treatment of nonerosive reflux disease or mild erosive esophagitis: a systematic review and meta-analysis","volume":"2018","author":"Khan","year":"2018","journal-title":"Gastroenterol Res Pract."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0550","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3748\/wjg.v24.i14.1550","article-title":"Maintenance for healed erosive esophagitis: phase III comparison of vonoprazan with lansoprazole","volume":"24","author":"Ashida","year":"2018","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0555","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.gie.2019.05.012","article-title":"ASGE guideline on screening and surveillance of Barrett\u2019s esophagus","volume":"90","author":"ASGE STANDARDS OF PRACTICE COMMITTEE","year":"2019","journal-title":"Gastrointest Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0560","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.gie.2019.05.030","article-title":"Systematic review and meta-analysis of prevalence and risk factors for Barrett\u2019s esophagus","volume":"90","author":"Qumseya","year":"2019","journal-title":"Gastrointest Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0565","doi-asserted-by":"crossref","first-page":"559","DOI":"10.14309\/ajg.0000000000001680","article-title":"Diagnosis and management of Barrett\u2019s esophagus: an updated ACG guideline","volume":"117","author":"Shaheen","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0570","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.cgh.2021.10.039","article-title":"Limitations of heartburn and other societies\u2019 criteria in Barrett\u2019s screening for detecting de novo esophageal adenocarcinoma","volume":"20","author":"Sawas","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0575","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/gutjnl-2013-305997","article-title":"Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett\u2019s oesophagus: a systematic review and meta-analysis","volume":"63","author":"Singh","year":"2014","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0580","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1542-3565(05)00153-9","article-title":"Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study","volume":"3","author":"Camilleri","year":"2005","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0585","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.14309\/ajg.0000000000000619","article-title":"Gastroesophageal reflux disease\u2014functional dyspepsia overlap: do birds of a feather flock together?","volume":"115","author":"Geeraerts","year":"2020","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0590","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MCG.0000000000001190","article-title":"Reflux symptoms in gastroparesis: correlation with gastroparesis symptoms, gastric emptying, and esophageal function testing","volume":"54","author":"Jehangir","year":"2020","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0595","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/nmo.12305","article-title":"The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastro\u2010esophageal reflux disease","volume":"26","author":"Pauwels","year":"2014","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0600","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.910929","article-title":"Overlap of gastroesophageal reflux disease and functional dyspepsia and yield of esophagogastroduodenoscopy in patients clinically fulfilling the Rome IV criteria for functional dyspepsia","volume":"9","author":"Quach","year":"2022","journal-title":"Front Med."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0605","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/00365521.2021.1929448","article-title":"How dyspepsia, gastroesophageal reflux symptoms, and overlapping symptoms affect quality of life, use of health care, and medication - a long-term population based cohort study","volume":"56","author":"Klausen","year":"2021","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0610","first-page":"639","article-title":"Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders","volume":"31","author":"de Bortoli","year":"2018","journal-title":"Ann Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0615","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1572-0241.2003.07699.x","article-title":"Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea","volume":"98","author":"Talley","year":"2003","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0620","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2036.2008.03596.x","article-title":"The influence of co\u2010morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro\u2010oesophageal reflux disease","volume":"27","author":"Nojkov","year":"2008","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0625","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.2007.145581","article-title":"Management of heartburn not responding to proton pump inhibitors","volume":"58","author":"Fass","year":"2009","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0630","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41395-018-0045-4","article-title":"Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel","volume":"113","author":"Yadlapati","year":"2018","journal-title":"The Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0635","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-3565(05)00860-8","article-title":"Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial","volume":"4","author":"Fass","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0640","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1365-2036.2000.00813.x","article-title":"Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro\u2010oesophageal reflux disease","volume":"14","author":"Lind","year":"2000","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0645","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4321\/S1130-01082012000700006","article-title":"Proton pump inhibitors in gastroesophageal reflux disease: \u201ca custom-tailored therapeutic regimen\u201d","volume":"104","author":"Sobrino-Cossio","year":"2012","journal-title":"Rev Esp Enferm Dig."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0650","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1365-2036.2000.00788.x","article-title":"Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors","volume":"14","author":"Stedman","year":"2000","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0655","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2005.02712.x","article-title":"Review article: putting immediate\u2010release proton\u2010pump inhibitors into clinical practice \u2013 improving nocturnal acid control and avoiding the possible complications of excessive acid exposure","volume":"22","author":"Katz","year":"2005","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0660","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cgh.2011.11.021","article-title":"Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release","volume":"10","author":"Fass","year":"2012","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0665","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3349\/ymj.2018.59.8.951","article-title":"Prospective single arm study on the effect of ilaprazole in patients with heartburn but no reflux esophagitis","volume":"59","author":"Song","year":"2018","journal-title":"Yonsei M\u00e9d J."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0670","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2036.2004.01949.x","article-title":"Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough","volume":"19","author":"Hammer","year":"2004","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0675","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s00535-017-1417-z","article-title":"Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study","volume":"53","author":"Kinoshita","year":"2018","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0680","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000497775","article-title":"Efficacy of vonoprazan, a novel potassium-competitive acid blocker, in patients with proton pump inhibitor-refractory acid reflux","volume":"101","author":"Akiyama","year":"2020","journal-title":"Digestion."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0685","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3892\/br.2017.947","article-title":"Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor-resistant gastroesophageal reflux disease","volume":"7","author":"Shinozaki","year":"2017","journal-title":"Biomed Rep."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0690","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5056\/jnm22104","article-title":"Effects of tegoprazan versus esomeprazole on nighttime heartburn and sleep quality in Gastroesophageal Reflux Disease: a multicenter double-blind randomized controlled trial","volume":"29","author":"Kim","year":"2022","journal-title":"J Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0695","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/j.gastro.2019.12.014","article-title":"Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms","volume":"158","author":"Delshad","year":"2020","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0700","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5056\/jnm.2011.17.4.387","article-title":"Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded","volume":"17","author":"Dickman","year":"2011","journal-title":"J Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0705","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0140-6736(00)04503-7","article-title":"Vanilloid receptor 1 immunoreactivity in inflamed human bowel","volume":"357","author":"Yiangou","year":"2001","journal-title":"Lancet."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0710","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1523\/JNEUROSCI.5679-03.2004","article-title":"Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia","volume":"24","author":"Amadesi","year":"2004","journal-title":"J Neurosci."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0715","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/00365520600973099","article-title":"Sensory and biomechanical properties of the esophagus in non-erosive reflux disease","volume":"42","author":"Reddy","year":"2007","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0720","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14056","article-title":"Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease","volume":"33","author":"Rengarajan","year":"2021","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0725","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/gutjnl-2016-311715","article-title":"Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett\u2019s oesophagus","volume":"65","author":"Fock","year":"2016","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0730","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14057","article-title":"The role of serotonin in the control of esophageal sensitivity assessed by multimodal stimulation in health","volume":"33","author":"Broers","year":"2021","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0735","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/ajg.2010.82","article-title":"Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial","volume":"105","author":"Lee","year":"2010","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0740","first-page":"6","article-title":"Efficacy of citalopram or amitriptyline versus no treatment in patients with functional chest pain","volume":"36","author":"Voulgaris","year":"2023","journal-title":"Ann Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0745","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mhj.2000.108514","article-title":"Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin","volume":"140","author":"Varia","year":"2000","journal-title":"Am Hear J."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0750","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrgastro.2016.50","article-title":"Management of refractory typical GERD symptoms","volume":"13","author":"Scarpellini","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0755","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/01.MLG.0000163746.81766.45","article-title":"Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton\u2010pump inhibitor therapy and pretherapy predictors of response","volume":"115","author":"Park","year":"2005","journal-title":"Laryngoscope."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0760","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.cgh.2018.02.001","article-title":"Extraesophageal symptoms and diseases attributed to GERD: where is the pendulum swinging now?","volume":"16","author":"Vaezi","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0765","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1053\/j.gastro.2018.08.038","article-title":"Model to select on-therapy vs off-therapy tests for patients with refractory esophageal or extraesophageal symptoms","volume":"155","author":"Patel","year":"2018","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0770","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1007\/s00268-017-4058-8","article-title":"Surgical treatment of extraesophageal manifestations of gastroesophageal reflux disease","volume":"41","author":"Sidwa","year":"2017","journal-title":"World J Surg."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0775","article-title":"Laparoscopic fundoplication surgery versus medical management for gastro\u2010oesophageal reflux disease (GORD) in adults","volume":"2015","author":"Garg","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0780","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1091-255X(99)80071-7","article-title":"Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication","volume":"3","author":"Campos","year":"1999","journal-title":"J Gastrointest Surg."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0785","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s11605-014-2584-3","article-title":"Outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease in non-responders to proton pump inhibitors","volume":"18","author":"Hamdy","year":"2014","journal-title":"J Gastrointest Surg."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0790","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1811424","article-title":"Randomized trial of medical versus surgical treatment for refractory heartburn","volume":"381","author":"Spechler","year":"2019","journal-title":"New Engl J Med."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0795","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s00464-012-2350-0","article-title":"The value of multiple rapid swallows during preoperative esophageal manometry before laparoscopic antireflux surgery","volume":"26","author":"Stoikes","year":"2012","journal-title":"Surg Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0800","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12876-016-0502-8","article-title":"A meta-analysis of long follow-up outcomes of laparoscopic Nissen (total) versus Toupet (270\u00b0) fundoplication for gastro-esophageal reflux disease based on randomized controlled trials in adults","volume":"16","author":"Du","year":"2016","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0805","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/lap.2007.0165","article-title":"Outcome of surgical fundoplication for extraesophageal (atypical) manifestations of gastroesophageal reflux disease in adults: a systematic review","volume":"18","author":"Iqbal","year":"2008","journal-title":"J Laparoendosc Adv Surg Tech."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0810","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJM199203193261202","article-title":"Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans","volume":"326","author":"Spechler","year":"1992","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0815","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.285.18.2331","article-title":"Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial","volume":"285","author":"Spechler","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0820","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1007\/s00464-021-08543-6","article-title":"Fundoplication is superior to medical therapy for Barrett\u2019s esophagus disease regression and progression: a systematic review and meta-analysis","volume":"36","author":"Wilson","year":"2022","journal-title":"Surg Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0825","doi-asserted-by":"crossref","first-page":"e8085","DOI":"10.1097\/MD.0000000000008085","article-title":"Laparoscopic Nissen (total) versus anterior 180\u00b0 fundoplication for gastro-esophageal reflux disease","volume":"96","author":"Du","year":"2017","journal-title":"Medicine."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0830","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMoa1205544","article-title":"Esophageal sphincter device for gastroesophageal reflux disease","volume":"368","author":"Ganz","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0835","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.cgh.2019.08.056","article-title":"Magnetic sphincter augmentation superior to proton pump inhibitors for regurgitation in a 1-year randomized trial","volume":"18","author":"Bell","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0840","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9596342","article-title":"Efficacy of magnetic sphincter augmentation versus nissen fundoplication for gastroesophageal reflux disease in short term: a meta-analysis","volume":"2017","author":"Chen","year":"2017","journal-title":"Can J Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0845","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00464-019-06950-4","article-title":"Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence","volume":"34","author":"Ayazi","year":"2020","journal-title":"Surg Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0850","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s00464-017-5859-4","article-title":"Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation","volume":"32","author":"Buckley","year":"2018","journal-title":"Surg Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0855","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1007\/s00464-016-5204-3","article-title":"Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias","volume":"31","author":"Rona","year":"2017","journal-title":"Surg Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0860","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s11605-018-3775-0","article-title":"Worldwide experience with erosion of the magnetic sphincter augmentation device","volume":"22","author":"Alicuben","year":"2018","journal-title":"J Gastrointest Surg."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0865","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cgh.2015.05.028","article-title":"Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux","volume":"14","author":"Ganz","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0870","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/dote.12199","article-title":"Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease","volume":"28","author":"Lipham","year":"2015","journal-title":"Dis Esophagus."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0875","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1007\/s00464-013-3010-8","article-title":"SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease (GERD)","volume":"27","author":"Auyang","year":"2013","journal-title":"Surg Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0880","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s00464-016-5111-7","article-title":"Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis","volume":"31","author":"Huang","year":"2017","journal-title":"Surg Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0885","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.gastro.2014.10.009","article-title":"Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial","volume":"148","author":"Hunter","year":"2015","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0890","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1055\/a-0576-6589","article-title":"Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis","volume":"50","author":"McCarty","year":"2018","journal-title":"Endoscopy."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0895","doi-asserted-by":"crossref","first-page":"E239","DOI":"10.1055\/a-1322-2209","article-title":"Long-term outcomes of transoral incisionless fundoplication for gastro-esophageal reflux disease: systematic-review and meta-analysis","volume":"09","author":"Testoni","year":"2021","journal-title":"Endosc Int Open."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0900","doi-asserted-by":"crossref","first-page":"E647","DOI":"10.1055\/a-0820-2297","article-title":"Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years","volume":"07","author":"Testoni","year":"2019","journal-title":"Endosc Int Open."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0905","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1553350614526788","article-title":"Transoral incisionless fundoplication effective in eliminating gerd symptoms in partial responders to proton pump inhibitor therapy at 6 months","volume":"22","author":"Trad","year":"2015","journal-title":"Surg Innov."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0910","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0016-5085(03)01052-7","article-title":"Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial","volume":"125","author":"Corley","year":"2003","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0915","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1007\/s00464-017-5431-2","article-title":"Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease","volume":"31","author":"Fass","year":"2017","journal-title":"Surg Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0920","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.gie.2020.01.037","article-title":"Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel","volume":"92","author":"Gawron","year":"2020","journal-title":"Gastrointest Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0925","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cgh.2014.10.013","article-title":"No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis","volume":"13","author":"Lipka","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0930","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1111\/j.1572-0241.2007.01452.x","article-title":"Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study","volume":"102","author":"Rey","year":"2007","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0935","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bpg.2007.05.006","article-title":"Gastroesophageal reflux disease in pregnancy","volume":"21","author":"Ali","year":"2007","journal-title":"Best Pr Res Clin Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0940","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2003.12.001","article-title":"Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease","volume":"126","author":"Johnson","year":"2004","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0945","first-page":"368","article-title":"Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications","volume":"95","author":"Richter","year":"2000","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0950","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijsu.2018.01.013","article-title":"Outcomes after laparoscopic anti-reflux surgery related to obesity: a systematic review and meta-analysis","volume":"51","author":"Abdelrahman","year":"2018","journal-title":"Int J Surg."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0955","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/000313481408000726","article-title":"Minimally invasive Roux-en-Y gastric bypass for fundoplication failure offers excellent gastroesophageal reflux control","volume":"80","author":"Kim","year":"2014","journal-title":"Am Surg."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0960","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1308\/003588407X205323","article-title":"Laparoscopic anti-reflux surgery is effective in obese patients with gastro-oesophageal reflux disease","volume":"89","author":"Ng","year":"2007","journal-title":"Ann R Coll Surg Engl."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0965","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00464-002-8955-y","article-title":"Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn","volume":"17","author":"Patterson","year":"2003","journal-title":"Surg Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0970","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s004640000392","article-title":"Obesity adversely affects the outcome of antireflux operations","volume":"15","author":"P\u00e9rez","year":"2001","journal-title":"Surg Endosc."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0975","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2036.2003.01394.x","article-title":"Baclofen decreases acid and non\u2010acid post\u2010prandial gastro\u2010oesophageal reflux measured by combined multichannel intraluminal impedance and pH","volume":"17","author":"Vela","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0980","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/apt.15274","article-title":"Gastric bypass surgery in the treatment of gastro\u2010oesophageal reflux symptoms","volume":"50","author":"Holmberg","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0985","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.soard.2010.09.011","article-title":"Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review","volume":"7","author":"Chiu","year":"2011","journal-title":"Surg Obes Relat Dis."},{"key":"10.1016\/j.rgmxen.2023.12.002_bib0990","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/archsurg.140.7.639","article-title":"Gastric banding interferes with esophageal motility and gastroesophageal reflux","volume":"140","author":"Suter","year":"2005","journal-title":"Arch Surg."}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X24000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X24000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:53:33Z","timestamp":1762419213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X24000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":198,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2255534X24000112"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2023.12.002","relation":{},"ISSN":["2255-534X"],"issn-type":[{"value":"2255-534X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2023.12.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}